Moderna (MRNA) PT Lowered to $375 at Jefferies; Sees Possible Q3 'Miss'
Tweet Send to a Friend
Jefferies analyst Michael Yee lowered the price target on Moderna (NASDAQ: MRNA) to $375.00 (from $485.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
